Cargando…

Factors associated with the availability and affordability of essential cardiovascular disease medicines in low- and middle-income countries: A systematic review

Despite their potential to prevent or delay the onset and progression of cardiovascular disease (CVD), medicines for CVD remain unavailable and unaffordable to many in low- and middle-income countries (LMICs). We systematically reviewed the literature to identify factors associated with availability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lotfizadeh, Ali, Palafox, Benjamin, Takallou, Armin, Balabanova, Dina, McKee, Martin, Murphy, Adrianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021589/ https://www.ncbi.nlm.nih.gov/pubmed/36962256 http://dx.doi.org/10.1371/journal.pgph.0000072

Ejemplares similares

Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
por: Chow, Clara Kayei, et al.
Publicado: (2020)

The Long and Winding Road: A Systematic Literature Review Conceptualising Pathways for Hypertension Care and Control in Low- and Middle-Income Countries
por: Brathwaite, Rachel, et al.
Publicado: (2020)

The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019)

Maintaining population health in low‐ and middle‐income countries during the COVID‐19 pandemic: Why we should be investing in Community Health Workers
por: Palafox, Benjamin, et al.
Publicado: (2020)

Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
por: Moye-Holz, Daniela, et al.
Publicado: (2020)

The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
por: Stolbrink, Marie, et al.
Publicado: (2022)

Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019)

Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country
por: Moye-Holz, Daniela, et al.
Publicado: (2017)

Coping with healthcare costs for chronic illness in low-income and middle-income countries: a systematic literature review
por: Murphy, Adrianna, et al.
Publicado: (2019)

The availability of essential medicines for cardiovascular diseases at healthcare facilities in low- and middle-income countries: The case of Bangladesh
por: Hakim, Shariful, et al.
Publicado: (2022)

Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings
por: Siddharthan, Trishul, et al.
Publicado: (2022)

Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
por: Husain, Muhammad Jami, et al.
Publicado: (2020)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)

Achieving affordable critical care in low-income and middle-income countries
por: Turner, Hugo C, et al.
Publicado: (2019)

What can global health institutions do to help strengthen health systems in low income countries?
por: Balabanova, Dina, et al.
Publicado: (2010)

Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review
por: Yenet, Aderaw, et al.
Publicado: (2023)

Correction to: Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
Publicado: (2020)

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector
por: Faust, Lena, et al.
Publicado: (2020)

Systematic review of frameworks used to conceptualise health pathways of individuals diagnosed with cardiovascular diseases
por: Seguin, Maureen L, et al.
Publicado: (2020)

Availability, prices and affordability of essential medicines in Haiti
por: Chahal, Harinder Singh, et al.
Publicado: (2013)

Comparing estimates of household expenditures between pictorial diaries and surveys in three low- and middle-income countries
por: Murphy, Adrianna, et al.
Publicado: (2023)

Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
por: Stolbrink, M., et al.
Publicado: (2022)

Improving access to affordable vaccines for middle-income countries in the african region
por: Mihigo, Richard, et al.
Publicado: (2019)

The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review
por: Gheorghe, Adrian, et al.
Publicado: (2018)

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
por: Bazargani, Y. T., et al.
Publicado: (2018)

GLOBAL PARTNERSHIP TO MAKE AVAILABLE 120 MILLION AFFORDABLE, QUALITY COVID-19 RAPID TESTS FOR LOW- AND MIDDLE-INCOME COUNTRIES
Publicado: (2020)

Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria
por: Orubu, Ebiowei S F, et al.
Publicado: (2019)

Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan
por: Sarwar, Muhammad Rehan, et al.
Publicado: (2018)

Availability, prices and affordability of essential medicines in Zhejiang Province, China
por: Dong, Zuojun, et al.
Publicado: (2020)

Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys
por: Yadav, Harika, et al.
Publicado: (2021)

Essential medicines for breast cancer in low and middle income countries
por: Bazargani, Y. T., et al.
Publicado: (2015)

Universities as catalysts of social innovation in health systems in low-and middle-income countries: a multi-country case study
por: van Niekerk, Lindi, et al.
Publicado: (2020)

Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan
por: Bibi, Murad, et al.
Publicado: (2022)

Crowdsourcing to identify social innovation initiatives in health in low- and middle-income countries
por: van Niekerk, Lindi, et al.
Publicado: (2020)

Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
por: Fathi, Mahdieh, et al.
Publicado: (2023)

Price, availability and affordability of medicines
por: Mhlanga, Brenda S., et al.
Publicado: (2014)

Availability and affordability of medicines for children
por: Kazaryan, Irina, et al.
Publicado: (2015)

Availability of cytotoxic medicines in the WHO essential medicine list used in treating childhood malignancies in low-income and lower-middle-income countries: a systematic review protocol
por: Seneviwickrama, Maheeka, et al.
Publicado: (2023)

Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries?
por: Beck, Eduard J., et al.
Publicado: (2019)

Prevalence and factors associated with the use of alternative (folk) medicine practitioners in 8 countries of the former Soviet Union
por: Stickley, Andrew, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_egbpi6i8jq0fcqtlln15v0aid6